LEADER 02244nam 2200637 450 001 9910808874303321 005 20230214220145.0 010 $a3-11-132319-6 024 7 $a10.1515/9783111323190 035 $a(CKB)3360000000514255 035 $a(EBL)3049683 035 $a(OCoLC)922950449 035 $a(SSID)ssj0001550230 035 $a(PQKBManifestationID)16161701 035 $a(PQKBTitleCode)TC0001550230 035 $a(PQKBWorkID)14807097 035 $a(PQKB)11353141 035 $a(MiAaPQ)EBC3049683 035 $a(DE-B1597)58639 035 $a(OCoLC)979812835 035 $a(DE-B1597)9783111323190 035 $a(Au-PeEL)EBL3049683 035 $a(CaPaEBR)ebr11009078 035 $a(CaONFJC)MIL806565 035 $a(EXLCZ)993360000000514255 100 $a20710211e19702014 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aProxemic behavior $ea cross-cultural study /$fO. Michael Watson 205 $aReprint 2014 210 1$aThe Hague :$cMouton,$d1970. 215 $a1 online resource (132 pages) $cillustrations 225 1 $aApproaches to semiotics ;$v8 300 $aDescription based upon print version of record. 311 0 $a3-11-098102-5 320 $aBibliography: pages [121]-127. 327 $tFrontmatter --$tPREFACE --$tTABLE OF CONTENTS --$tI. INTRODUCTION --$tII. THE STRUCTURING OF SPACE IN ANIMALS AND MAN --$tIII. METHODOLOGY --$tIV. ANALYSIS OF THE DATA --$tV. THE COMMUNICATIVE ASPECTS OF PROXEMIC BEHAVIOR --$tVI. SUMMARY AND CONCLUSIONS --$tAPPENDIX A: Proxemics Research Questionnaire --$tAPPENDIX B: Proxemics Research Interview --$tBIBLIOGRAPHY 410 0$aApproaches to semiotics ;$v8. 606 $aSpace perception 606 $aPersonal space 606 $aPersonality and culture$vCross-cultural studies 615 0$aSpace perception. 615 0$aPersonal space. 615 0$aPersonality and culture 676 $a153 700 $aWatson$b O. Michael$0178330 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910808874303321 996 $aProxemic behavior$91552647 997 $aUNINA LEADER 03046oam 2200505I 450 001 9910136148503321 005 20230810001133.0 010 $a1-315-57587-6 010 $a1-317-15471-1 010 $a1-317-15472-X 024 7 $a10.4324/9781315575872 035 $a(CKB)3710000000912531 035 $a(MiAaPQ)EBC4717886 035 $a(OCoLC)960901855 035 $a(BIP)56234562 035 $a(BIP)49259584 035 $a(EXLCZ)993710000000912531 100 $a20180706d2017 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 10$aDarwin's medicine $ehow business models in the life sciences industry are evolving /$fBrian D. Smith 205 $aFirst edition. 210 1$aNew York :$cRoutledge,$d2017. 215 $a1 online resource (296 pages) $cillustrations, tables 300 $a"A Gower Book"--cover. 311 08$a1-4724-2071-3 320 $aIncludes bibliographical references and index. 327 $apt. 1. The future of pharma : reprise -- pt. 2. An immeasurably superior power -- pt. 3Evolution is cleverer than you are -- pt. 4. Guiding the blind watchmaker. 330 $aDarwin's Medicine is the sequel to Brian D. Smith's influential and critically acclaimed Future of Pharma (Gower, 2011). Whereas the earlier book predicted the evolution of the pharmaceutical market and the business models of pharmaceutical companies, Darwin's Medicine goes much deeper into the drivers of industry change and how leading pharmaceutical and medical technology companies are adapting their strategies, structures and capabilities in practice. Through the lens of evolutionary science, Professor Smith explores the speciation of new business models in the Life Sciences Industry. This sophisticated and highly original approach offers insights into: The mechanisms of evolution in this exceptional industry; The six great technological and social shifts that are shaping its landscape; The emergence of 26 distinct, new business models; and The lessons that enable firms to direct and accelerate their own evolution. These insights map out the industry's complex, changing landscape and provide an invaluable guide to those firms seeking to survive and thrive in this dynamic market. The book is essential reading for anyone working in or studying the pharmaceutical, medical technology and related sectors. It provides a unique and novel way of making sense of the transformation we can see going on around us and a practical, focused approach to managing a firm's evolutionary trajectory. ? 606 $aPharmaceutical industry 606 $aBiotechnology industries 615 0$aPharmaceutical industry. 615 0$aBiotechnology industries. 676 $a338.476151 700 $aSmith$b Brian D$g(Brian David),$f1961-,$0282302 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910136148503321 996 $aDarwin's medicine$92223849 997 $aUNINA